The Cycle Exchange LLC – Trademark Portfolio

Entity Type: 16

The Cycle Exchange LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include 1E9, COUTURE TRADERS, THE CYCLE EXCHANGE, and C · BUY · SELL · TRADE. The owner is based in Andover, NJ.

65 Main St

Andover, NJ 07821

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

The Cycle Exchange LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does The Cycle Exchange LLC have?

The Cycle Exchange LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does The Cycle Exchange LLC file in?

The Cycle Exchange LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 25 (Clothing). Class 35 covers advertising; business management; business administration; office functions.

What are The Cycle Exchange LLC's most well-known trademarks?

The Cycle Exchange LLC's registered trademark portfolio includes well-known marks such as 1E9, COUTURE TRADERS, THE CYCLE EXCHANGE, and C · BUY · SELL · TRADE. These are among 4 currently registered trademarks in the portfolio.

What is The Cycle Exchange LLC's trademark registration success rate?

The Cycle Exchange LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.